AI-generated summary
This review revisits the antidepressant effects of transcranial photobiomodulation, which uses near-infrared light delivered through the skull to the brain cortex. The authors searched PubMed and ClinicalTrials.gov for clinical studies of t-PBM in major depressive disorder and treatment-resistant depression. The abstract does not report a pooled finding or the strength of the evidence.
- Who or what was studied
- Patients diagnosed with major depressive disorder or treatment-resistant depression
- Limits stated in the abstract
- The abstract does not state the number of included studies, their quality, or the strength of the evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Depression, Transcranial photobiomodulation, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.